Lumenis Surgical Division

What Lumenis Surgical Division does

Lumenis Surgical Division (legal entity: Lumenis Be Ltd) is a privately held Israeli medical device company that develops and commercializes energy-based systems, including laser, Intense Pulsed Light (IPL), and Radio Frequency (RF) platforms, for the global aesthetic and ophthalmology markets. The company operates two product divisions: Aesthetics, offering facial muscle stimulation (triLift), hair loss treatment (FoLix), CO2 ablative resurfacing (UltraPulse Alpha, AcuPulse), multi-application platforms (Stellar M22, M22), RF platforms (Legend Pro+, NuEra Tight), and hair removal systems (SPLENDOR X, LightSheer QUATTRO); and Vision, offering dry eye treatment (OptiLIGHT, OptiPLUS, OptiLIFT), glaucoma management (Digital Duet/Trio, Selecta Duet/Trio), and retinal photocoagulation systems (Smart532, Vision One, Array LaserLink) plus surgical accessories (LumeProbe, Smart LIO, slit lamps). Proprietary technology platforms include Dynamic Muscle Stimulation (DMSt), TriPollar RF, Optimal Pulse Technology (OPT), SureSpot Optics, and SmartPulse sub-threshold technology.

Lumenis generates revenue through direct enterprise field sales of capital equipment to licensed medical practitioners, supplemented by recurring service contracts and consumable sales (notably LumeProbe endophotocoagulation probes). Devices are sold on a custom quote basis with multi-year contracts, distributed via direct sales teams, the Lumenis Partner Zone portal, and regional websites across the US, Australia, France, Germany, Italy, Japan, and the UK. The company is owned by EQT Private Capital Asia and led by CEO Tzipi Ozer-Armon, with an installed base of over 90,000 devices across 88+ countries, 500+ clinical publications, and 60+ years of industry leadership since founding in 1964. The primary customer segments are aesthetic practices (medical spas, dermatology, plastic surgery) and ophthalmology/optometry practices, with a growing extension into hair restoration clinics driven by the FoLix platform.

Name

Lumenis Surgical Division

Legal name

Lumenis Be Ltd

Website

https://lumenis.com

Company type

Private

Founded year

1964

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Lumenis is a privately held Israeli medical device company that develops and sells laser, IPL, and RF energy-based systems for global aesthetic and ophthalmology practices, with 90,000+ devices installed across 88+ countries.

Ownership category

akta.pro rank

Product category

Medical Aesthetic and Ophthalmic Laser Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)

akta.pro industry

PRIMARYHLAKACAF

Laser & Energy-Based Dermatology

Healthcare & Life Sciences/Specialist Medical Practice/Dermatology

SECONDARYCRABAKAI

Skincare Devices (Cleansing Brushes, Microcurrent, LED, Dermaplaning)

Consumer Products & Retail/Beauty & Personal Care/Beauty Tools & Accessories

Keywords

• Medical laser systems
• Aesthetic medical devices
• Ophthalmic laser equipment
• Energy-based devices
• IPL phototherapy systems

Headquarters

HQ city

San Jose

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Medical Device Hardware Sales: Sale of energy-based medical devices including laser systems, IPL platforms, and RF equipment to aesthetic and ophthalmic practices
2. Surgical Probes and Accessories: Sale of consumable and semi-consumable accessories including LumeProbe endophotocoagulation laser probes in various gauges and configurations
3. Service and Support: Service contracts, technical support, and maintenance services for installed device base

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Core offering

Lumenis develops, manufactures, and commercializes energy-based medical devices — including laser, Intense Pulsed Light (IPL), and Radio Frequency (RF) platforms — for the aesthetic and ophthalmic/vision markets. The product portfolio spans facial muscle stimulation, skin resurfacing, hair removal, body contouring, hair loss treatment, dry eye management, glaucoma therapy, and retinal photocoagulation, supported by consumable probes, accessories, and service contracts sold primarily through direct enterprise sales to licensed medical practitioners, dermatology/aesthetic practices, ophthalmology clinics, and hospitals.

Product overview

Lumenis develops and commercializes energy-based medical devices for aesthetic and vision care markets. The company offers a portfolio of laser, Intense Pulsed Light (IPL), and Radiofrequency (RF) technologies organized into two divisions: Aesthetics and Vision. In Aesthetics, the core platforms include Stellar M22 and M22 (multimodal systems supporting IPL, ResurFX, Nd:YAG, and Q-Switched modules), ULTRApulse Alpha and AcuPulse (CO2 laser systems for skin resurfacing and scar treatment), triLift (facial muscle stimulation with DMSt technology), FoLix (FDA-cleared non-ablative fractional laser for hair loss), SPLENDOR X and LightSheer QUATTRO (laser hair removal), Legend Pro+ and Legend Pro (RF platforms for skin tightening), NuEra Tight (body contouring), and FemTouch (women's health). In Vision, key products include OptiLIGHT and OptiPLUS (dry eye treatment with IPL and RF), OptiLIFT (periorbital muscle stimulation), Digital Duet and Digital Trio (SLT/YAG glaucoma platforms), Smart532 and Vision One (photocoagulators), LumeProbe (endo-photocoagulation probes), Smart LIO (laser indirect ophthalmoscopes), and compatible slit lamp systems. Lumenis products are sold in 88+ countries worldwide with over 90,000 devices installed globally.

Differentiator

Problem solved

Functional benefit

Brands

• Pollogen: Consumer aesthetic technology brand
• triLift
• FoLix
• OptiLIGHT
• Stellar M22
• LightSheer
• UltraPulse
• AcuPulse
• Legend Pro+
• NuEra Tight
• SPLENDOR X
• SmoothGlo
• FemTouch
• Smart LIO

Products and services

• FoLix The first and only FDA-cleared non-ablative fractional laser (NAFL) for hair loss treatment. Uses proprietary NAFL technology to stimulate hair follicles by creating microscopic thermal zones (MTZs) that trigger regenerative response without damaging surrounding tissue. Sold to hair restoration specialists and medical practices.
• triLift Facial muscle stimulation device using proprietary Dynamic Muscle Stimulation (DMSt) combined with TriPollar RF and triFX RF microneedling. Delivers a toned, lifted effect without surgery, injectables, or downtime by dynamically addressing facial muscles. Sold to aesthetic practices.
• Stellar M22
• M22 Multi-application aesthetic platform serving as the cornerstone of aesthetic practices. Modular design allowing practices to add IPL, ResurFX, Nd:YAG, and Q-Switched modules as needed. Sold to dermatology and aesthetic practices.
• SPLENDOR X Hair removal laser system featuring BLEND X technology that combines Alexandrite and Nd:YAG wavelengths for effective treatment across all skin types. Sold to medical spas, dermatology, and aesthetic practices.
• ULTRApulse Alpha The most powerful CO2 laser in aesthetic medicine with exceptional ablation/coagulation ratio. Features DeepFX, ActiveFX, TotalFX, and SCAAR FX modes for skin resurfacing, scar revision, acne scars, and blepharoplasty. Can penetrate up to 3.5mm depth. Sold to plastic surgery and dermatology practices.
• AcuPulse Versatile CO2 laser with 10 built-in treatment modes for ablation and resurfacing. Treats more than 30 FDA-cleared aesthetic indications including sun damage, acne scars, blepharoplasty, and moles. Features Compact Pattern Generator (CPG) and AcuScan120 scanner options. Sold to aesthetic and dermatology practices.
• Legend Pro+ 4-in-1 RF platform combining RF microneedling, TriPollar RF, and volumetric heating. Treats scars, acne scars, striae, self-injury scars, and provides skin tightening and toning. Sold to dermatology and aesthetic practices.
• LightSheer QUATTRO Diode laser hair removal system offering effective treatments with advanced cooling technology for patient comfort across various skin types. Sold to medical spas, dermatology, and aesthetic practices.
• NuEra Tight Radiofrequency body contouring device targeting cellulites and skin tightening. Uses controlled RF energy for non-invasive body sculpting treatments. Sold to aesthetic and dermatology practices. (Note: a US-specific configuration is sold as 'NuEra Tight US'.)
• FemTouch CO2 laser vaginal rejuvenation treatment for women's health. Addresses vaginal atrophy and provides laser-assisted vaginal tightening treatments. Sold to OB/GYN and women's health practices.
• OptiLIGHT IPL (Intense Pulsed Light) device specifically designed for dry eye treatment due to Meibomian Gland Dysfunction (MGD). FDA-cleared for the treatment and management of dry eye. Sold to ophthalmology and optometry practices.
• OptiLIFT Dynamic muscle stimulation device for non-surgical toning of periorbital muscles to address droopy eyelids. Uses transcutaneous electrical stimulation for dry eye symptoms. Health Canada approved; sold to ophthalmology and optometry practices.
• OptiPLUS Groundbreaking dual frequency RF technology complementing OptiLIGHT's dry eye solution. Provides additional therapeutic benefits for ocular surface disease. Sold to ophthalmology and optometry practices.
• Digital Duet The first and only all-in-one digital platform for Glaucoma and PCO (posterior capsule opacification) therapies. Combines SLT and YAG technologies in a single system. Sold to ophthalmology practices and eye surgery centers.
• Digital Trio 3-in-1 digital platform combining SLT, YAG, and Smart532 technologies for comprehensive glaucoma and retina care in a single device. Sold to ophthalmology practices and eye surgery centers.
• Smart Selecta Duet SLT (Selective Laser Trabeculoplasty) and YAG photodisruptor combined in one platform for glaucoma management. Sold to ophthalmology practices.
• Smart Selecta Trio Comprehensive platform combining SLT, YAG, and Smart532 technologies for retinal, cataract, and glaucoma therapy in one system. Sold to ophthalmology practices.
• Smart532 Green photocoagulator with SmartPulse sub-threshold technology for retinal photocoagulation treatments. Features advanced pulse technology for improved patient outcomes. Sold to ophthalmology and retina practices.
• Vision One Multi-wavelength photocoagulator offering green, yellow, and red wavelengths for versatile retinal photocoagulation treatments. Modular design for clinical flexibility. Sold to ophthalmology and retina practices.
• LumeProbe Premium ophthalmic endophotocoagulation laser probes designed for retinal specialists. Features concentric laser burns, optimized energy transmission via SMA connectors, enhanced safety, and reliability. Available in straight, curved, stepped, illuminated, and aspirating types in 20, 23, and 25 gauge sizes. Sold to retinal surgeons.
• Smart LIO (Laser Indirect Ophthalmoscope) Advanced Laser Indirect Ophthalmoscope offering superior performance with built-in versatility and maximum safety. Features coaxial illumination, aiming and treatment beams, integrated three-wavelength eye safety filters, and maximized stereopsis. Sold to retinal specialists.

Quantifiable outcome

• 96.9% correct identification of before/after images by dermatologists in FoLix clinical study of 98 patients
• +5 more outcomes

Named customers10 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration7 records

Feature9 records

Partnerships

Five partnerships are on record, tiered notable and core.

• NYU Dermatology DepartmentnotableStrategic or Co-development PartnerClinical partnership for FoLix fractional laser hair loss technology validation and research collaboration in dermatological applications.
• Bauman MedicalnotableStrategic or Co-development PartnerPartnership with Dr. Alan Bauman's hair restoration practice for clinical validation and adoption of FoLix hair loss treatment technology.
• BosleycoreStrategic or Co-development PartnerStrategic collaboration with Bosley, the largest hair restoration chain in the US, accelerating clinical adoption and patient access to FoLix technology across their nationwide clinic network.
• Itay Mayer (Chief Commercial Officer)coreOthersChief Commercial Officer leading Lumenis' commercial strategy and global go-to-market initiatives.
• Tzipi Ozer-Armon (CEO)coreOthersCEO of Lumenis providing strategic leadership and vision for the company's position in energy-based medical devices.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Cynosure: Cynosure (a Hologic company) is a direct competitor in energy-based aesthetic devices including lasers, IPL, and RF platforms used by dermatologists, plastic surgeons, and medspas — the same core customer and technology categories as Lumenis' aesthetics business.
• Alma Lasers: Alma Lasers (Sisram Medical) is a direct competitor offering a broad portfolio of laser, IPL, RF, and ultrasound-based aesthetic and surgical platforms sold into dermatology, plastic surgery, and medical spa channels globally.
• Cutera: Cutera is a direct competitor in energy-based aesthetic devices (laser hair removal, IPL, RF microneedling) targeting the same dermatology and medspa customer base as Lumenis' aesthetics platforms such as Stellar M22, SPLENDOR X, and LightSheer QUATTRO.
• Sciton: Sciton is a direct competitor offering premium laser and light-based platforms (BBL, Halo, MOXI) for aesthetic practices, overlapping directly with Lumenis' M22 and UltraPulse platforms in dermatology and plastic surgery offices.
• BTL Aesthetics: BTL is a direct competitor in non-invasive aesthetic devices, particularly in body contouring, skin tightening, and muscle stimulation (EMSculpt) — directly overlapping with Lumenis' triLift DMSt technology and NuEra Tight RF body platform.
• InMode: InMode is a direct competitor in RF-based aesthetic and gynecological platforms (Morpheus8, BodyTite, Evolve) and women's health (Mona Lisa Touch-era devices), competing with Lumenis' Legend Pro+, NuEra Tight, and FemTouch product lines.
• Solta Medical (Bausch Health): Solta Medical (Thermage, Fraxel, Clear+Brilliant, VASER) is a direct competitor in energy-based aesthetic devices, with overlapping use cases in skin resurfacing and rejuvenation against Lumenis' UltraPulse Alpha, AcuPulse, and ResurFX.
• El.En. S.p.A. (DEKA, Asclepion): El.En. S.p.A. owns DEKA and Asclepion, which manufacture medical laser systems for aesthetics, dermatology, gynecology, and surgery — competing directly with Lumenis' CO2 (UltraPulse/AcuPulse), IPL, and surgical laser portfolios.

Emerging players

• Venus Concept: Venus Concept is an emerging player offering energy-based aesthetic devices (Venus Versa, Venus Bliss, Venus Legacy) targeting similar medical aesthetics and medspa customers with a focus on subscription-based commercial models.
• Iridex: Iridex is a smaller peer in the ophthalmic laser segment, offering retinal photocoagulation and glaucoma laser systems that partially overlap with Lumenis' Vision division products (Smart532, Vision One, Digital Duet/Trio).

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xx.com/lumenisinc
• YouTubeyoutube.com/user/LumenisInc/featured
• Facebookfacebook.com/lumenis
• LinkedInlinkedin.com/company/11124
• Instagraminstagram.com/lumenis.aesthetic

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Lumenis Surgical Division